5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats

Pain

Volumn 99, Issue 1-2, 2002, Pages 133-143

  Okamoto, Keiichiro ^a   Imbe, Hiroki ^a   Morikawa, Yoshihiro ^a   Itoh, Masayuki ^a   Sekimoto, Masashi ^b   Nemoto, Kiyomitsu ^b   Senba, Emiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Calcitonin gene related peptide; Dorsal root ganglion; Inflammatory pain; Nerve growth factor; Serotonin; Serotonin 2A receptor

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FREUND ADJUVANT; MESSENGER RNA; PROTEIN; PROTEIN RET; RECEPTOR SUBTYPE; SARPOGRELATE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LATENT PERIOD; LONG TERM POTENTIATION; MALE; NERVE COMPRESSION; NERVE FIBER TRANSECTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE; SPINAL GANGLION; WITHDRAWAL REFLEX;

ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; GANGLIA, SPINAL; HINDLIMB; MALE; NERVE FIBERS; NEURALGIA; NEUROGENIC INFLAMMATION; NEURONS, AFFERENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN ANTAGONISTS; SUCCINATES;

EID: 0036710228     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00070-2     Document Type: Article

References (53)

1. Abbott F.V., Hong Y., Blier P. Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 35:1996;99-100.
2. Alhaider A.A. Antinociceptive effect of ketanserine in mice: involvement of supraspinal 5HT2 receptors in nociceptive transmission. Brain Res. 543:1991;335-340.
3. Amara S.G., Arriza J.L., Leff S.E., Swanson L.W., Evans R.M., Rosenfeld M.G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 229:1985;1094-1097.
4. Anden N.E., Olsson Y. 5-Hydroxytryptamine in normal and sectioned rat sciatic nerve. Acta Pathol Microbiol Scand. 70:1967;537-540.
5. Bardin L., Lavarenne J., Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain. 86:2000;11-18.
6. Beck P.W., Handwerker H.O. Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pfugers Arch. 347:1974;209-222.
7. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
8. Boucher T.J., Okuse K., Bennett D.L., Munson J.B., Sood J.N., McMahon S.B. Potent analgesic effects of GDNF in neuropathic pain states. Science. 290:2000;124-127.
9. Canzian F., Ushijima T., Nagao M., Matera I., Romeo G., Ceccherini I. Genetic mapping of the RET protooncogene on rat chromosome 4. Mamm Genome. 6:1995;433-435.
10. Carlton S.M., Coggeshall R.E. Immunohistochemical localization of 5-HT2A receptors in peripheral sensory axons in rat glabrous skin. Brain Res. 763:1997;271-275.
11. Chen J.J., Vasko M.R., Wu W., Staeva T.P., Baez M., Zgombick J.M., Nelson D.L. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther. 287:1997;1119-1127.
12. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett. 184:1995;5-8.
13. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol. 364:1996;6-15.
14. Doi-Saika M., Tokunaga A., Senba E. Intradermal 5-HT induced Fos expression in rat dorsal horn neurons not via 5-HT3 but via 5-HT2A receptors. Neurosci Res. 29:1997;143-149.
15. Du Y-L., Wilcox B.D., Teitler M., Jeffrey J.J. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmcol. 45:1994;1125-1131.
16. Ernberg M., Lundeberg T., Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain. 84:2000;339-346.
17. Eschalier A., Kayser V., Guilbaud G. Influence of specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain. 36:1989;249-255.
18. Giordano J., Dyche J. Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology. 28:1989;423-427.
19. Giordano J., Rogers L.V. Peripherally administrated serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol. 170:1989;83-86.
20. Grubb B.D., McQueen D.S., Iggo A., Birrell G.J., Dutia M.B. A study of 5-HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions. 25:1988;216-218.
21. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
22. Herbert M.K., Schmidt R.F. Activation of normal and inflamed fine articular afferent units by serotonin. Pain. 50:1992;79-88.
23. Horigome K., Pryor J.C., Bullock E.D., Johnson E.M. Jr. Mediator release from mast cells by nerve growth factor. J Biol Chem. 268:1993;14881-14887.
24. Hrycaj P., Stratz T., Mennet P., Muller W. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome - a preliminary study. J Rheumatol. 23:1996;1418-1423.
25. Julius D., Huang K.N., Livelli T.J., Axel R., Jessel T. The 5-HT2A receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci USA. 87:1990;928-932.
26. Kashiba H., Hyon B., Senba E. Glial cell line-derived neurotrophic factor and nerve growth factor receptor mRNAs are expressed in distinct subgroups of dorsal root ganglion neurons and are differentially regulated by peripheral axotomy in the rat. Neurosci Lett. 252:1998;107-110.
27. Kashiba H., Ueda Y., Senba E. Coexpression of preprotachykinin A (PPTA), α-calcitonin gene related peptide (α-CGRP), somatostatin (SOM) and neurotrophin receptor family mRNAs in rat dorsal root ganglion neurons. Neuroscience. 70:1996;179-189.
28. Kawauchi S., Ohishi K., Matsumoto H., Nishizawa N., Kuroda M. Clinical effect of sarpogrelate hydrochloride on the patients with reflex sympathetic dystrophy syndrome. Pain Clinic. 16:1995;61-64.
29. Kiefel J.M., Paul D., Bodner R.J. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2A receptor antagonists. Brain Res. 612:1989;289-298.
30. Komatsu T., Enjouji S., Nakai H., Inokuchi T., Iida S. Studies on the metabolic fate of (+)-2-(Dimethylamino)-1-[[o-m-methoxyphenethyl)-phenoxy]methyl]ethyl hydrogen succinate hydrochloride (MCI-9042) (II): absorption, distribution, metabolism and excretion after a single administration to rats. Yakubutsu Dotai. 6:1991;377-398. [abstract in English].
31. Lewin G.R., Rueff A.M., Mendell L.M. Peripheral and central mechanism of NGF induced hyperalgesia. Eur J Neurosci. 6:1994;157-203.
32. Maeshima T., Ito R., Hamada S., Senzaki K., Hamaguchi-Hamada K., Shutoh F., Okado N. The cellular localization of 5-HT2A receptors in the spinal cord and spinal ganglia of the adult rat. Brain Res. 797:1998;118-124.
33. Mannion R.J., Costigan M., Decosterd I., Amaya F., Ma Q.P., Holstege J.C., Ji R.R., Acheson A., Lindsay R.M., Wilkinson G.A., Woolf C.J. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA. 96:1999;9385-9390.
34. Moesker A. The role of a serotonin antagonist in the treatment of an autonomic nervous system related pain syndrome. Pain Clinic. 12:1991;290-295.
35. Molliver D.C., Wright D.E., Leitner M.L., Parsadanian A.S., Doster K., Wen D., Yan Q., Snider W.D. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron. 19:1997;849-861.
36. Orwin J.M., Forzard J.R. Blockade of the fare response to intradermal 5-hydroxytryptamine in man by MDL 72.222, a selective antagonist at neuronal 5-hydroxytryptamine receptors. Eur J Clin Pharmacol. 30:1986;209-212.
37. Page C.P. Platelets as inflammatory cells. Immunopharmacology. 17:1989;51-59.
38. Pierce P.A., Xie G.X., Levine J.D., Peroutka S.J. 5-Hydroxytryptamine receptor subtype messanger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience. 70:1996;553-559.
39. Rang H.P., Bevan S., Dray A. Chemical activation of nociceptive peripheral neurones. Brit Med Bull. 47:1991;534-548.
40. Richardson B.P., Engel G., Donatsch P., Stadler P.A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 316:1985;126-131.
41. Scott M.A., Fone K.C.V. Modulation of calcitonin gene-related peptide release from dorsal thoraco-lumbar spinal cord slices by 5-HT3 receptors. Neurosci Lett. 175:1994;5-8.
42. Snider W.D., McMahon S.B. Tackling pain at the source: new ideas about nociceptors. Neuron. 20:1998;629-632.
43. Sufka K.J., Schomburg F.M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav. 41:1991;53-56.
44. Tecott L.H., Maricq A.V., Julius D. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci USA. 90:1993;1430-1434.
45. Theodosiou M., Rush R.A., Zhou X.F., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve damage: role of nerve growth factor. Pain. 81:1999;245-255.
46. Thompson S.W.N., Bennett D.L.H., Kerr B.J., Bradbury E.J., McMahon S.B. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci USA. 96:1999;7714-7718.
47. Todorovic S., Anderson E.G. 5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Res. 511:1990;71-79.
48. Tokunaga A., Saika M., Senba E. 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain. 76:1998;349-355.
49. Verge V.M., Ricardson P.M., Wiesesfeld-Hallin Z., Hokfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci. 15:1995;2081-2096.
50. Wu C., Yoder E.J., Shih J., Chen K., Dias P., Shi L., Ji X-D., Wei J., Conner J.M., Kumar S., Ellisman M.H., Singh S.K. Development and characterzation of monoclonal antibodies specific to the serotonin 5-HT2A receptor. J Histochem Cytochem. 46:1998;811-824.
51. Yoder E.J., Tamir H., Ellisman M.H. Serotonin receptors expressed by myelinating Schwann cells in rat sciatic nerve. Brain Res. 753:1997;299-308.
52. Zhu Q-S., Chen K., Shih J.C. Characterization of the human 5-HT2A receptor gene promoter. J Neurosci. 15:1995;4885-4895.
53. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.